Get In Touch

Expertise Areas

US & Global Market Access Strategy

HEOR Evidence Generation Strategy

Economic Modeling for Budget Impact Analysis

Economic Modeling for Cost Effectiveness Analysis

US & Global Pricing Strategy

Global Value Dossier Development

Payer Segmentation Analysis

Medical Device Reimbursement Strategy

Rare Disease Products

Value Assessment for M&A or Licensing

Meta-Analysis (NMA, Frequentist, Bayesian)

References for All Recent Projects are Available Upon Request. Email us for Details or to Request for More Information.

Recent HEOR Projects

HEOR Evidence Development Strategy for Novel First in Class Product (Multiple Projects, Recent Project Rated "Phenomenal Work Product")

Economic Modeling for Blockbuster Product (Multiple Projects)

Budget Impact Modeling for Myeloma Blockbuster Product (US Managed Care, Recent BIM Rated "Giant Leap")

GVD for Blockbuster Product (Multiple Projects)

GVD Development, CE and BIA Modeling for Asia-Pacific (For 2014 Submission to BNHI)

Comparative Effectiveness Meta-Analysis Study (w/ Johnson & Johnson, Presented at ISPOR, Abstract in Public Domain)

HTA & Guidelines Review and Strategic Implications

HEOR & Payer Publication Strategy for Blockbuster Product

HEOR Disease Landscape (Multiple Myeloma and HCV)

Full Day HEOR and Market Access Fundamentals Workshop in Paris, France (Final Feedback "Best and Easy to Understand Workshop")

iPhone/iPad App for Chronic Kidney Disease Patients (App Programmed by NOVEL)

Recent Market Access Projects

40 Country Pricing and Reimbursement Strategy

2020 P&R Vision for Oncology Market (Assessment Aided in Acquisition of Cancer Biotech for $2.5B)

P&R Assessment for Ten Fixed Dose Combinations

15 Country Reimbursement Strategy for Novel Medical Device Product

Value Proposition Development for Breakthrough Neurology Product (US&EU)

US & Global Market Access Strategy for Ultra Orphan Product

NPV/DCF Valuation for Neurology Product

Strategy Market Access and Pricing Ad-Boards (Recent Ad-Board Rated as "Top 3 Best Ad-Boards")

Patient Access Program Design Strategy for First-in-Class Oncology Product

Analog Analysis for Product Launch Pricing and Access Case Study

Market Access and HTA Comprehensive Landscape Assessment and Annual Tracking for Strategic Implications (Multiple Projects)


NOVEL Won Two Platinum and Bronze Medal Awards at AMCP

NOVEL's team won two Platinum and Bronze Medal Awards for Presentations at AMCP Nexus Educational Conference at Boston.

Read More

Podium & Poster Presentations at HTAi 2014 DC

At the Health Technology Assessment HTAi Annual 2014 Meeting in Washington, DC, NOVEL's team was selected for podium and poster presentations.

Read More

Top Strategy Mishaps of 2011-2012

NOVEL's team analyzed all product launches of 2011 and 2012 and developed a list of top strategy mishaps. This report also presents the lessons learned and implications for future products.

Read More

HEOR, Pricing and Marketing Strategy for Cancer Therapies

Oncology is the highest selling indication for pharmaceutical products. In a recent event NOVEL's team discussed the 10-years trends in oncology drug development.

Read More

Developing GVD for Pricing & Market Access Success

GVD is the single and central strategy resource for pricing and reimbursement of medical products. NOVEL's team recently hosted a webinar on strategies for developing GVDs.

Read More

Economic Models for HTAs, Payers and Providers

Economic models are becoming important tools for demonstrating economic value of new products. In our recent event we presented fundamentals of developing models, interactive design and easy-to-update features.

Read More